This study aimed to analyze the incidence of tuberculosis (TB), AIDS and tuberculosis-AIDS co-infection in the municipality of Campinas, in the state of São Paulo, Brazil, in the period 2001 – 2009. A historical trend study, it uses secondary data from the Tuberculosis Surveillance Database of the University of Campinas (UNICAMP) and the São Paulo State STD-AIDS Center of Excellence and Training. It included new cases of TB, AIDS, and of tuberculosis-AIDS reported in the municipality of Campinas. A decrease in cases of TB until 2007 was observed, with an increase in 2008 and 2009. There was a general reduction in AIDS from 2007, but with an increase among men aged 60 or over, in the years 2007 to 2009. For tuberculosis-AIDS co-infection, the tendency was to reduce. The proportion of HIV tests not undertaken, among patients with tuberculosis, was high (27.5%). This scenario shows the need for integration of the databanks into the planning and control activities.
Introduction: The mortality rate among tuberculosis patients (TB fatality) has been attributed to irregular chemotherapy, delay in diagnosis, multidrug resistance, and HIV coinfection. Objective: To analyze TB fatality rates by sex, clinical presentation and HIV coinfection in Campinas, São Paulo, Brazil. Methods: Cohorts of residents in the city of Campinas who either died during treatment for tuberculosis or had the disease confirmed after death were divided into three intervals: 2001-2003, 2004-2006, and 2007-2009. Data were obtained from the database of the Tuberculosis Surveillance System of the University of Campinas, and notifications were gathered through TB-WEB Health São Paulo Secretary. Statistical significance was determined using a chi-square test, considering p < 0.05. Results: Between 2001 and 2009, 3,416 TB patients were diagnosed: 2,827 (82.8%) were new TB cases and 589 (17.2%) were retreatments. Between the first and second triennium, the number of new patients decreased by 18%, and 23% among retreatments. Between the second and third intervals, the reduction was 5% and 21%, respectively. General case fatality rate declined from 11.4% to 9.9% across intervals, and was most significant among patients that had previously abandoned treatment (17.3% to 5.1%). Fatality rates among patients coinfected with TB-AIDS were 2-3 times that of patients not infected with TB-AIDS throughout the intervals. Fatality between the first and third triennium among TB-AIDS co-infected patients declined (24.8% to 19.5%), while increasing slightly among non-AIDS TB patients (7.3% to 8%) during this period. Conclusion: Though mortality among TB-AIDS patients declined from 2001-2009, rates among non-AIDS TB remained stagnant. Improved TB diagnosis and treatment is needed to further decrease TB mortality in Campinas.
Resumo Objetivo: identificar e analisar os fatores de risco à infecção pelo HIV entre adolescentes e jovens. Método: trata-se de uma revisão sistemática que teve como questão norteadora: quais são os fatores de risco à infecção pelo HIV entre adolescentes e jovens?”. As buscas em cinco bases de dados e no Google Scholar ocorreram em dezembro de 2021, tendo como filtro publicações entre 2012-2022 sem limitação de idiomas. As publicações foram selecionadas por dois revisores independentes. Os materiais incluídos foram submetidos à avaliação da qualidade metodológica e a uma síntese narrativa. Resultados: recuperou-se 26.191 materiais, sendo sete artigos incluídos. Todos os estudos foram conduzidos na África. Identificou-se que o sexo feminino, a maior idade dos jovens, baixa escolaridade, pessoas negras, múltiplas parcerias sexuais, uso inconsistente de preservativos, consumo de álcool e início sexual precoce constituíram fatores de risco para a infecção pelo HIV em adolescentes e jovens. Conclusão: a compreensão dos fatores de risco alicerça a propositura de políticas de saúde e estratégias de intervenção com a finalidade de fortalecer a capacidade de resposta dos serviços de saúde e o cuidado da equipe de enfermagem para a diminuição da transmissão do HIV entre adolescentes e jovens.
Introduction: Prisons context has the potential for the spread of infectious diseases, like HIV and tuberculosis, which prevalence is higher in the people deprived of liberty compared to the general population. Objective: to analyze which are the determinants of coinfection tuberculosis and HIV in prisons. Methodology: Case-control study conducted in the state of São Paulo, Brazil. New cases of tuberculosis in the population deprived of liberty in the period between 2015 and 2017 were considered. Data were obtained through the notification and monitoring system for tuberculosis cases in the state of São Paulo and included sociodemographic and clinical variables and diagnosis and treatment information. The data were analyzed through frequency distribution and bivariate analysis, testing the association of the dependent variable (tuberculosis/HIV coinfection vs. tuberculosis/HIV non-coinfection) with independent variables (sociodemographic, clinical and diagnostics variables) by calculating the odds ratio and p-value. Results: Among the determinants of tuberculosis/HIV coinfection in prisons, we identified: age between 26-35, 36-55 and 56-84 years, notification in hospitals, negative sputum smear microscopy and culture, X-ray suggestive of another pathology, extrapulmonary and mixed clinical form, and alcoholism. A high percentage of death was also identified among coinfected people. Conclusions: identifying the determinants of the tuberculosis/HIV coinfected individual can assist in the development and implementation of guidelines aimed at controlling both infections in the prison environment.
Objetivo: descrever os fatores sociodemográficos, diagnósticos e clínicos associados ao local de notificação da tuberculose entre pessoas privadas de liberdade. Métodos: estudo caso-controle, com dados coletados de pessoas privadas de liberdade diagnosticadas como casos novos de tuberculose no período de 2015 a 2017 no sistema de informação em tuberculose do estado de São Paulo. Os casos compreenderam os indivíduos notificados fora do sistema prisional e os controles aqueles notificados dentro do sistema prisional, com razão de pareamento igual a três. As variáveis de exposição incluíram: dados sociodemográficos, de diagnóstico e clínicos e foram analisadas por meio da distribuição de frequência e análise univariada. Resultados: foram notificados 5.764 casos de tuberculose no sistema prisional. Apresentam maior chance para notificação fora do sistema prisional as pessoas da raça/cor branca e preta, que tiveram o diagnóstico durante a internação, cultura de escarro negativo e não realizado, forma clínica extrapulmonar e pulmonar+extra, diabetes mellitus e uso de drogas. Conclusões: o estudo mostrou as potencialidades do sistema prisional para a detecção dos casos de tuberculose, no entanto, apresenta limitações que vem sendo transpostas por meio da articulação com os serviços que compõem a rede de atenção em saúde.
Objective: to identify and analyze HIV infection risk factors among adolescents and the youth. Method: this is a systematic review whose guide question is: what are the risk factors for HIV infection among adolescents and the youth?” In total, five databases and Google Scholar were searched in December 2021 and the found publications between 2012-2022 were filtered without language restriction. Studies were selected by two independent reviewers. The included materials were subjected to methodological quality evaluation and narrative synthesis. Results: overall, we included seven studies out of the 26,191 retrieved. All studies were conducted in Africa. We found that the female gender, older age, low schooling, Black ethnicity, multiple sexual partners, inconsistent use of condoms, alcohol consumption, and early sexual onset constituted risk factors for HIV infection in adolescents and the youth. Conclusion: understanding risk factors underscores the provision of health policies and intervention strategies to strengthen the responsiveness of health services and nursing teams’ care to reduce HIV transmission among adolescents and the youth.
OBJETIVO Identificar e sintetizar o conhecimento científico produzido a respeito da efetividade do teste GeneXpert no diagnóstico da tuberculose (TB) pulmonar em pessoas vivendo com HIV/aids. MÉTODOS Revisão integrativa da literatura, cuja busca foi feita nas plataformas Embase, Scopus, PubMed, Cinahl, Academic Search Premier, Socindex e Lilacs, em dezembro de 2019. Os estudos levantados passaram por duas etapas de seleção: leitura dos títulos e resumos por dois revisores de forma independente, utilizando a plataforma Rayyan e leitura integral dos mesmos. Foram incluídos 19 estudos primários em inglês, português e espanhol que respondiam à pergunta norteadora do estudo: Qual é a efetividade do teste GeneXpert no diagnóstico da TB pulmonar em pessoas que vivem com HIV/aids? RESULTADOS A utilização do GeneXpert aumentou substancialmente a detecção de casos de TB entre a população coinfectada com HIV, com sensibilidade que variou de 68% a 100%, sendo superior à baciloscopia. A especificidade variou de 91,7% a 100%; o valor preditivo positivo, de 79,2% a 96,1%; e o valor preditivo negativo, de 84,6% a 99,3%, valores considerados semelhantes à baciloscopia pela maioria dos estudos. O teste também foi comparado com as diferentes formas de realização da cultura e outros testes moleculares, sendo considerado inferior apenas ao Xpert Ultra. CONCLUSÃO É possível afirmar que locais com alta incidência de HIV se beneficiariam com a implantação do teste GeneXpert, uma vez que sua efetividade no diagnóstico da TB pulmonar nessa população é expressiva quando comparada à baciloscopia, teste que foi por muito tempo amplamente utilizado para a detecção dos casos.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.